Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06956898

The Effect of Mindfulness-Based Intervention and Haptonomy Application on Birth Self-Efficacy, Prenatal Attachment and Anxiety Levels of Pregnant Women With Fear of ChildBirth

Fear of childbirth is a common condition encountered during pregnancy. Women with fear of childbirth have reduced birth self-efficacy, and it leads to mental health problems in the prenatal and postnatal periods, reducing mother-infant bonding. Therefore, it is of critical importance to implement effective and applicable interventions focused on health and well-being to reduce fear of childbirth. Considering the increasing cesarean section rates today, holistic intervention strategies that can positively affect the birth experiences of pregnant women and support their psychological well-being are needed. In this sense, mindfulness and haptonomy applications, which are holistic intervention strategies, will allow us to meet the psychological and emotional needs of pregnant women with fear of childbirth and improve their birth experiences.

No study has been found in the literature that systematically evaluates the effects of a holistic intervention strategy for women with fear of childbirth during pregnancy. This study will enable the development of new and effective intervention strategies that can be used in prenatal and postnatal care practices and will guide clinical practices to make pregnant women's birth experiences more positive. In this study, the effects of mindfulness-based intervention and haptonomy application on childbirth self-efficacy, prenatal attachment and anxiety levels in pregnant women experiencing fear of childbirth will be evaluated. This research will be conducted as a randomized controlled experimental study. The data of the research will consist of 225 women (75 in the mindfulness group, 75 in the haptonomy group, and 75 in the control group) who applied to the Erzurum City Hospital Gynecology and Obstetrics Clinic between 01.06.2024 and 01.07.2025. The data will be collected face to face using the "Personal Information Form", "Wijma Childbirth Expectation/Experience Scale Version A", "Prenatal Attachment Inventory", and "State Anxiety Scale".

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a primary school graduate,
  • Women in their 28th week of pregnancy,
  • Being primigravida,
  • Women with a healthy pregnancy,
  • Women with a Wijma Childbirth Expectation/Experience Scale version A score of ≥38,
  • Women who agree to participate in the study and do not have any chronic health problems that would prevent them from participating.

Exclusion criteria

  • Pregnant women who did not agree to participate in the study or who left the study at any stage of the study will constitute the study.

Treatment and study plan

Mindfulness training

Other

Primiparous pregnant women in the experimental (mindfulness) group will be given training for 8 weeks starting from the 28th week.

Haptonomy Training

Other

Primiparous pregnant women in the experimental (mindfulness) group will be given training for 8 weeks starting from the 28th week.

Primary outcomes

  1. Change in Childbirth Fear

    Time frame: "Baseline (28th week of pregnancy)" and "Post-test immediately after the training" and "Post-test 2 weeks after the training"

    Change in Fear of Childbirth Measure: Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ-A) Description: The W-DEQ-A is a 33-item Likert-type scale developed to assess fear of childbirth, labor-related thoughts and emotions, and anticipated stress. Each item is scored from 0 ("completely") to 5 ("not at all"), with some items reverse-coded. Total scores range from 0 to 165. Higher scores indicate greater fear of childbirth.

    Unit of Measure: Score on W-DEQ-A (0-165) Time Frame: Baseline (Week 28), immediately after training (Week 37), and two weeks after training (Week 39)

  2. Change in Childbirth Self-Efficacy

    Time frame: "Baseline (28th week of pregnancy)" and "Post-test immediately after the training" and "Post-test 2 weeks after the training"

    Measure: Childbirth Self-Efficacy Inventory (CSEI)

    Description: The CSEI measures women's confidence in coping with labor. It consists of 32 items divided into two subscales: outcome expectancy and efficacy expectancy. Each item is rated on a scale from 1 to 10. Total scores range from 32 to 320. Higher scores reflect greater self-efficacy during childbirth.

    Unit of Measure: Score on CSEI (32-320)

    Time Frame: Baseline (Week 28), immediately after training (Week 37), and two weeks after training (Week 39)

  3. Change in Prenatal Attachment

    Time frame: "Baseline (28th week of pregnancy)" and "Post-test immediately after the training" and "Post-test 2 weeks after the training"

    Measure: Prenatal Attachment Inventory (PAI)

    Description: The PAI is a 21-item instrument used to assess a pregnant woman's emotional attachment to her unborn baby. Items are scored from 1 to 4. Total scores range from 21 to 84. Higher scores indicate stronger prenatal attachment.

    Unit of Measure: Score on PAI (21-84)

    Time Frame: Baseline (Week 28), immediately after training (Week 37), and two weeks after training (Week 39)

  4. Change in Trait Anxiety

    Time frame: "Baseline (28th week of pregnancy)" and "Post-test immediately after the training" and "Post-test 2 weeks after the training"

    Measure: State-Trait Anxiety Inventory - Trait Form (STAI-T)

    Description: The STAI-T measures an individual's general tendency to experience anxiety. The scale consists of 20 items rated on a 4-point Likert scale. Total scores range from 20 to 80. Higher scores indicate higher levels of trait anxiety.

    Unit of Measure: Score on STAI-T (20-80)

    Time Frame: Baseline (Week 28), immediately after training (Week 37), and two weeks after training (Week 39)

Other outcomes

  1. Personal Information Form

    Time frame: "Baseline (28th week of pregnancy)"

    This form was developed by the researchers based on the relevant literature. It is used to collect the socio-demographic and obstetric information of the participants and their perceptions about birth. Data obtained will be used to describe sample characteristics and for subgroup analysis purposes. It is not considered a primary or secondary outcome measure.

    The topics covered are; Age group, Educational status, Employment status, Income level, Last menstrual period, Week of gestation, Whether the pregnancy was planned or not, Access to prenatal care, Labor pain and fear of childbirth, Attitudes towards awareness, haptonomy and perceived effectiveness of prenatal care in reducing fear of childbirth

    Participants respond using multiple choice or yes/no options. Responses will be analyzed descriptively and used to investigate associations with primary outcomes where appropriate.

    Baseline (28th week of pregnancy)

Study contacts

Contact information is provided by the study sponsor or research team.

Hafsa Kübra Işık, Research Assistant, MSc

CONTACT

[email protected]

+90 546 540 44 22

Sponsors and collaborators

Lead sponsor

Bayburt University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
May 4, 2025
Registry last updated
May 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.